ADAR and breast cancer: Revealing the functional and mechanistic impacts of ADAR1-mediated A>I(G) RNA editing in BC on the response to genotoxic drugs could reveal a new source of potential novel therapeutic strategies and molecular markers for better prognosis and treatment outcomes in patients with BC.